MONAS
FINANCIAL
Home
About
Research
Data
Pricing
Team
News
Analysis
Press
Contact
Legal
← News
Cantor Fitzgerald Reiterates Neutral on Amgen, Maintains $400 Price Target
Analyst Ratings
AMGN
Sep 8
AI-curated analysis for informational purposes only — not investment advice.
Cantor Fitzgerald Reiterates Neutral on Amgen, Maintains $400 Price Target
Read the full story at benzinga.com →